July 23, 2015
SutroVax raises $22 million in Series A

June 22, 2015
Corcept Therapeutics Appoints Daniel Swisher to Board of Directors

June 19, 2015
Medtronic Acquires Aptus Endosystems

June 18, 2015
Aimmune Therapeutics Receives FDA Breakthrough Therapy Designation for AR101

June 18, 2015
Calhoun Vision Expands Executive Team With Proven Ophthalmic Industry Veterans

June 18, 2015
Practice Fusion is the Market Share Leader for Solo and Small Clinician Practices

June 15, 2015
Esperion Therapeutics Announces the Appointment of Scott Braunstein, M.D. to Board of Directors

June 8, 2015
Collegium Announces Issuance of U.S. Patent Covering DETERx(R) - an Abuse-Deterrent, Extended-Release Technology Platform

June 7, 2015
Aimmune Therapeutics Announces Positive Phase 2 Study Results of AR101 for the Treatment of Peanut Allergy

June 4, 2015
Calhoun Vision Raises $69 Million in Financing

June 1, 2015
Collegium Expands Commercial Organization With Key Appointments

May 27, 2015
Allergen Research Corporation Renamed Aimmune Therapeutics

May 20, 2015
Venus Vivaô receives FDA clearance for dermatological procedures requiring ablation and resurfacing of the skin

May 19, 2015
Practice Fusion and the American Urological Association Collaborate to Launch Overactive Bladder Population Health Management Initiative

May 18, 2015
Allergen Research Corporation Names Mark McDade as Chairman and Mark Iwicki as Member of the Board of Directors

May 18, 2015
Prospective Patient Registry Demonstrates the Corus CAD Test Score Impacts Real-World Clinical Decision-Making in Patients Presenting with Symptoms Suggestive of Obstructive Coronary Artery Disease

May 18, 2015
Encore Dermatology, Inc., A New Specialty Dermatology Company

May 13, 2015
Corcept Therapeutics' Mifepristone Combined with Eribulin to Improve Antitumor Activity in Patients with Triple-Negative Breast Cancer

May 7, 2015
Collegium Pharmaceutical Announces Pricing of Its Initial Public Offering

May 6, 2015†
ALPHAEON Appoints Hon. Christopher Cox and Dennis Wolf to Board of Directors

May 1, 2015
Alphatec Spine Announces Appointment of Donald A. Williams to its Board of Directors

May 6, 2015
Rapid Micro Biosystems Announces New Chief Financial Officer

April 29, 2015
Rapid Micro Biosystems Secures $25 Million in Series C Equity Financing

April 29, 2015
Stealth Foundry Grad Twelve Racks Up $35M for Percutaneous Mitral Valve Replacement

April 21, 2015
Allergen Research Corporation Announces New CFO Warren DeSouza and Board of Directors Audit Committee Chair Kate Falberg

April 17, 2015
PRN's Omega-3 Hits Major Endpoints Against Placebo in a Study of Dry Eye Symptoms

April 16, 2015
ALPHAEON Expands ALPHAEONMD Practice System with Launch of ENGAGEMD

April 14, 2015
Practice Fusion and ePatientFinder Partner to Launch One of the Nationís Largest EHR-Based Clinical Trial Networks

April 13, 2015
Practice Fusion and AstraZeneca Partner on Population Health Management Initiative for Asthma and Chronic Obstructive Pulmonary Disease

April 8, 2015
Allergen Research Corporation Expands Management with New VP Functions

April 1, 2015
Warrant Exercises Generate $17.2 Million; Proceeds to Advance Next-Generation Compounds and Support Commercialization of Korlym.

April 1, 2015
CardioDx Announces Positive Results from Clinical Utility Study Evaluating the Corus CAD Blood Test's Influence on Clincial Decision Making in the Assessment of Obstructive Coronary Artery Disease in Women

March 24, 2015
Esperion Therapeutics Announces Closing of Follow-On Public Offering and Exercise in Full of Underwriters' Option to Purchase Additional Shares of Common Stock.

March 12, 2015
Allergen Research Corporation Completes $80 Million Series B Financing to Advance Drug Development Portfolio for Food Allergy

March 10, 2015
Collegium Raises $50 Million Financing to Support Commercial Development of its Lead Abuse-Deterrent Product Candidate.

March 6, 2015
Amarin Announces $52.8 Million Private Placement

March 4, 2015
Corcept Recorded Net Revenue of 9.0 Million in the Fourth Quarter of 2014, Compared to $4.1 Million for the Same Period in 2013. The Company Estimates 2015 Net Revenue Will Be Between $47 Million and $53 Million.

February 26, 2015
Collegium Pharmaceutical Announces Notice of Allowance for U.S. Patent Covering DETERx, and Abuse-Deterrent Analgesic for Chronic Pain

February 17, 2015
CoverMyMeds and Practice Fusion Partner to Bring Electronic Prior Authorizations for Medications to Over 110,000 of Practice Fusionís Users

February 15, 2015
Healthy Women and the National Association of Nurse Practitioners in Women's Health are Partnering with CardioDx on a New Patient Advocacy Campaign to Empower Women to be Proactive in Discussing Their Heart Health and Testing Options with Their Healthcare Providers. It's Called Spread the Word.

February 9, 2015
Collegium Pharmaceutical Appoints Chief Financial Officer and New Member to its Board of Directors.

January 15, 2015
ALPHAEON Corporation Closes Series A Preferred Stock Financing In A Transaction Led By Longitude Capital Management Co., LLC.

January 14, 2015
Flamel Sinks on Jazz Pharma Patent Ruling

© 2015 Longitude Capital Management Co., LLC. All rights reserved.